ViewRay Systems, Inc. designs, manufactures, and markets magnetic resonance imaging radiation therapy system in the United States and internationally. The company offers MRIdian A3i, an MRI-guided radiation therapy system that provides real-time 3D tissue tracking and automated beam control. Its product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company was founded in 2004 and is headquartered in Oakwood, Ohio. On July 16, 2023, ViewRay, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. On October 26, 2023, the voluntary petition of ViewRay, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on July 16, 2023.
The current price of VRAYQ is $0.00 USD — it has decreased by -99% in the past 24 hours. Watch ViewRay stock price performance more closely on the chart.
What is ViewRay stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange ViewRay stocks are traded under the ticker VRAYQ.
Is ViewRay stock price growing?▼
VRAYQ stock has fallen by -99% compared to the previous week, the month change is a -99% fall, over the last year ViewRay has showed a -90% decrease.
What is ViewRay revenue for the last year?▼
ViewRay revenue for the last year amounts to 102.21M USD.
What is ViewRay net income for the last year?▼
VRAYQ net income for the last year is -107.33M USD.
How many employees does ViewRay have?▼
As of July 08, 2026, the company has 295 employees.
In which sector is ViewRay located?▼
ViewRay operates in the Health & Wellness sector.
When did ViewRay complete a stock split?▼
The last stock split for ViewRay was on July 08, 2015 with a ratio of 1.1857630000000001:1.
Where is ViewRay headquartered?▼
ViewRay is headquartered in Oakwood, United States.